Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) — Cash Flow Quality Index
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) has a Cash Flow Quality Index of 2.32x as of June 2023. Operating cash flow of €2.10 Billion exceeds net income of €902.65 Million, indicating high earnings quality where cash backs reported profits. Explore how much of Guangzhou Baiyunshan Pharmaceutical Hold's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Cash Flow Quality Index (2013–2025)
Historical Cash Flow Quality Index for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Guangzhou Baiyunshan Pharmaceutical Hold (GU5) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (2013–2025)
Year-by-year earnings quality comparison for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited. For live market cap and the full company financial profile, see Guangzhou Baiyunshan Pharmaceutical Hold market cap and net worth.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -0.08x | €-232.46 Million | €2.98 Billion | ▼ -106.4% |
| 2024 | 1.21x | €3.44 Billion | €2.84 Billion | ▲ +20.0% |
| 2023 | 1.01x | €4.10 Billion | €4.06 Billion | ▼ -42.7% |
| 2022 | 1.76x | €7.00 Billion | €3.97 Billion | ▲ +15.7% |
| 2021 | 1.53x | €5.67 Billion | €3.72 Billion | ▲ +659.8% |
| 2020 | 0.20x | €585.19 Million | €2.92 Billion | ▼ -87.3% |
| 2019 | 1.57x | €5.02 Billion | €3.19 Billion | ▲ +3.9% |
| 2018 | 1.52x | €5.22 Billion | €3.44 Billion | ▲ +70.5% |
| 2017 | 0.89x | €1.83 Billion | €2.06 Billion | ▼ -47.3% |
| 2016 | 1.69x | €2.54 Billion | €1.51 Billion | ▲ +13.0% |
| 2015 | 1.49x | €1.94 Billion | €1.30 Billion | ▲ +2.0% |
| 2014 | 1.46x | €1.75 Billion | €1.19 Billion | ▲ +7.4% |
| 2013 | 1.36x | €1.34 Billion | €980.05 Million | — |